Cargando…
Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis
Autores principales: | Lee, Chanju, Lee, Hyunji, Cho, Hayoon, Kim, Soyoung, Choi, Ilseob, Hwang, Young‐Sik, Jeong, Hyunju, Jang, Hogi, Pak, Sehyun, Hwang, Deok‐Sang, Han, Ik‐Hwan, Bae, Hyunsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017751/ https://www.ncbi.nlm.nih.gov/pubmed/35171513 http://dx.doi.org/10.1002/cac2.12276 |
Ejemplares similares
-
Therapeutic Effect of Melittin–dKLA Targeting Tumor-Associated Macrophages in Melanoma
por: Han, Ik-Hwan, et al.
Publicado: (2022) -
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
por: Kim, Soyoung, et al.
Publicado: (2022) -
Magnolol Attenuates Cisplatin-Induced Muscle Wasting by M2c Macrophage Activation
por: Lee, Chanju, et al.
Publicado: (2020) -
Evaluation of the Efficacy and Safety of the Herbal Formula PM014 in a Cisplatin- and Paclitaxel-Treated Tumor-Bearing Mouse Model
por: Lee, Chanju, et al.
Publicado: (2020) -
TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
por: Lee, Chanju, et al.
Publicado: (2022)